Últimas noticias sobre Brenmiller Energy (NASDAQ:BNRG) Bolsa

Brenmiller Energy

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

AVXL

BLIN

BNRG

LMNR

QCOM

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: LMNR, QCOM, AVXL, BNRG y BLIN.

5 acciones en el foco este lunes: LMNR, QCOM, AVXL, BNRG y BLIN

Brenmiller Energy Ltd

Fresh Del Monte Produce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) shares are <a href="https://www.benzinga.com/movers">trading lower on Wednesday</a> after the first-quarter full year 2025 earnings.
The company reported a <a href="https://www.benzinga.com/pressreleases/25/04/b45093636/fresh-del-monte-produce-inc-reports-first-quarter-earnings-for-fiscal-2025">first-quarter revenue decline</a> of 0.9% year-on-year to $1.10 billion, missing the analyst consensus estimate of $1.11 billion.
The decrease in net sales was primarily driven by lower net sales in the company&#8217;s banana segment primarily as a result of lower sales volume and the negative impact of fluctuations in exchange rates.
Adjusted EPS of $0.63 <a href="https://www.benzinga.com/earnings">missed the consensus</a> estimate of $0.68.
Also Read: <a href="https://www.benzinga.com/news/25/04/45078934/dominos-pizza-will-grow-with-stuffed-crust-doordash-partnership-say-analysts">Domino&#8217;s Pizza Will Grow With Stuffed Crust &amp; DoorDash Partnership, Say Analysts</a>
Gross profit jumped 12% Y/Y to $92.2 million, and the profit margin expanded 100 basis points to 8.4%.
The operating margin was 4%, and operating income for the quarter remained flat at 44.9 million.
Adjusted EBITDA jumped 40.9% to $61.3 million with an adjusted EBITDA margin of 5.7%.
The operating cash flow for the quarter totaled $46.1 million.
On April 29, 2025, the company&#8217;s board of directors declared a quarterly cash dividend of $0.30 per share, payable on June 6, 2025, to shareholders of record on May 14, 2025.
The company held $34.4 million in cash and equivalents as of March 28, 2025. Long-term debt as of the end of the quarter decreased to $233 million from $244 million as of the end of 2024.
FDP Price Action:  Fresh Del Monte Produce shares traded lower by 3.19% at $33.66 at publication on Wednesday.
Read Next: • <a href="https://www.benzinga.com/news/25/04/45074719/levi-strauss-shareholders-stand-by-dei-policy-amid-political-pushback">Levi Strauss Shareholders Stand By DEI Policy Amid Political Pushback</a>
Photo: Postmodern Studio via Shutterstock

General

Fresh Del Monte Stock Falls As Q1 Sales, Earnings Miss Expectations

Wells Fargo analyst Aaron Rakers maintains Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) with a Equal-Weight and lowers the price target from $120 to $105.

Price Target

Analyst Ratings

Wells Fargo Maintains Equal-Weight on Seagate Tech Hldgs, Lowers Price Target to $105

Susquehanna analyst Shyam Patil maintains Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) with a Neutral and lowers the price target from $50 to $38.

CRTO

Susquehanna Maintains Neutral on Criteo, Lowers Price Target to $38

Wells Fargo analyst Aaron Rakers maintains CommVault Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) with a Overweight and raises the price target from $180 to $190.

CVLT

Wells Fargo Maintains Overweight on CommVault Systems, Raises Price Target to $190

Wells Fargo analyst Andrew Nowinski maintains Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Overweight and lowers the price target from $50 to $40.

TENB

Wells Fargo Maintains Overweight on Tenable Holdings, Lowers Price Target to $40

Wells Fargo analyst Ken Gawrelski maintains Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Equal-Weight and lowers the price target from $9 to $8.

SNAP

Wells Fargo Maintains Equal-Weight on Snap, Lowers Price Target to $8

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Wednesday.
The Dow traded down 0.47% to 40,335.51 while the NASDAQ dipped 1.22% to 17,248.37. The S&amp;P 500 also fell, dropping, 0.83% to 5,514.48.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/45098110/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a>
Leading and Lagging Sectors Consumer staples shares rose by 0.3% on Wednesday.
In trading on Wednesday, energy stocks dipped by 3.3%.
Top Headline
The EIA reported that U.S. crude oil inventories declined by 2.696 million barrels in the week ended April 25, versus market estimates of a 0.39 million barrel gain.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Regulus Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGLS#NASDAQ">RGLS</a>) shares shot up 131% to $7.78 after the company announced it entered into an agreement to be acquired by Novartis AG for $7 in cash per share.</li>
<li>Shares of Jeffs&#8217; Brands Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>)got a boost, surging 45% to $1.23 after the company announced the sale of its Smart Repair Pro business for $11.8 million.</li>
<li>INVO Fertility, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVF#NASDAQ">IVF</a>) shares were also up, gaining 75% to $2.8150 after the company announced fourth-quarter results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Vicor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) shares dropped 20% to $41.33 after the company reported first-quarter financial results and missed its EPS and sales estimates.</li>
<li>Shares of GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) were down 40% to $70.47 after the company posted first-quarter results.</li>
<li>Wabash National Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNC#NYSE">WNC</a>) was down, falling 28% to $7.13 after the company reported worse-than-expected first-quarter financial results and issued FY25 guidance below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 3.4% to $59.75 while gold traded down 0.6% at $3,314.70.
Silver traded down 2.1% to $32.865 on Wednesday, while copper fell 5.7% to $4.5935.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.46%, Germany's DAX 40 rose 0.32% and France's CAC 40 gained 0.50%. Spain's IBEX 35 Index fell 0.59%, while London's FTSE 100 rose 0.37%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei gaining 0.57%, China's Shanghai Composite falling 0.23%, Hong Kong's Hang Seng Index gaining 0.51% and India's BSE Sensex falling 0.06%.
Economics
<ul>
<li>The U.S. economy shrank at an annualized rate of 0.3% during the first quarter of 2025, following a 2.4% growth in the prior quarter.</li>
<li>Private business in the U.S. created 62,000 workers to their payrolls in April following a revised 147,000 payrolls in the earlier month.</li>
<li>The Chicago PMI declined to 44.6 in April versus 47.6 in the previous month.</li>
<li>The EIA reported that U.S. crude oil inventories declined by 2.696 million barrels in the week ended April 25, versus market estimates of a 0.39 million barrel gain.</li>
<li>U.S. pending home sales rose 6.1% month-over-month in March, compared to markt estimates of 1%.</li>
<li>The core PCE price index came in unchanged from the previous month in March.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/media/25/04/45098332/jim-cramer-this-tech-stock-is-not-great-not-bad-alaska-air-can-still-go-lower">Jim Cramer: This Tech Stock Is &#8216;Not Great, Not Bad&#8217;, Alaska Air Can Still Go Lower</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

JFBR

RGLS

VICR

Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher

Wells Fargo analyst Ken Gawrelski maintains Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) with a Equal-Weight and raises the price target from $4567 to $4692.

BKNG

Wells Fargo Maintains Equal-Weight on Booking Holdings, Raises Price Target to $4692

Snap Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) reported better-than-expected first-quarter <a href="https://www.benzinga.com/quote/SNAP/earnings">financial results on Tuesday</a>.
Snap reported first-quarter revenue of $1.36 billion, up 14% year-over-year. The revenue total beat a Street consensus estimate of $1.35 billion according to data from Benzinga Pro. The company reported an adjusted loss of 8 cents per share, beating a Street consensus estimate of a loss of 13 cents per share.
Snap had 460 million daily active users at the end of the first quarter, up 9% year-over-year. The company also passed the milestone figure of 900 million monthly active users, on its way to a goal of one billion MAU.&nbsp;
&#8220;We surpassed an important milestone in Q1, with our community growing to over 900 million monthly active users,&#8221; Snap CEO Evan Spiegel said.
Snap shares fell 14.7% to trade at $7.75 on Wednesday.
These analysts made changes to their price targets on Snap following earnings announcement.
<ul>
<li>Rosenblatt analyst Barton Crockett maintained Snap with a Neutral and lowered the price target from $12 to $9.</li>
<li>BMO Capital analyst Brian Pitz maintained the stock with an Outperform rating and lowered the price target from $16 to $13.</li>
<li>RBC Capital analyst Brad Erickson, meanwhile, reiterated Snap with a Sector Perform and maintained a $12 price target.</li>
</ul>
Considering buying SNAP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30122130/image-238-1024x584.png" alt="" class="wp-image-895376" style="width:614px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30122130/image-238-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30122130/image-238-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30122130/image-238-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30122130/image-238.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

These Analysts Cut Their Forecasts On Snap Following Q1 Results

Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>) with a Neutral and lowers the price target from $20 to $16.

XRAY

Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $16

Wells Fargo analyst Michael Berg maintains Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) with a Underweight and raises the price target from $11 to $12.

FRSH

Wells Fargo Maintains Underweight on Freshworks, Raises Price Target to $12

Wells Fargo analyst Andrew Bauch maintains Shift4 Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) with a Overweight and raises the price target from $100 to $111.

FOUR

Wells Fargo Maintains Overweight on Shift4 Payments, Raises Price Target to $111

Piper Sandler analyst Jason Bednar maintains Henry Schein (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) with a Overweight and lowers the price target from $83 to $77.

HSIC

Piper Sandler Maintains Overweight on Henry Schein, Lowers Price Target to $77

Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) on Wednesday posted a first-quarter adjusted EPS of $11.58, up from $7.23 a year ago,&nbsp;beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $10.07</a>.
Humana sales increased from $29.6 billion to $32.11 billion, slightly missing the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45093637/humana-reports-first-quarter-2025-financial-results-affirms-full-year-2025-adjusted-financial-guid" rel="noreferrer noopener">consensus of $32.22 billion</a>.
The revenue was driven by higher per-member Medicare and state-based contract premiums. The Medicare increase was primarily driven by an increased direct subsidy due to the Inflation Reduction Act (IRA) and membership growth in the company&#8217;s stand-alone PDP and state-based contracts businesses.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44927473/despite-medicaid-pressure-elevance-health-delivers-strong-q1-performance-reiterates-profit-outlook" rel="noreferrer noopener">Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook</a>
Humana&nbsp;ended the first quarter with 14.84 million in total medical membership, down from 16.35 million in December 2024 and 16.17 million in March 2024. Individual Medicare Advantage membership&nbsp;<a target="_blank" href="https://humana.gcs-web.com/static-files/ef339ddf-83f9-4333-8f2d-4f97fe1e4bcb" rel="noreferrer noopener">reached</a> 5.22 million, down from 5.55 million a year ago.
1Q25 Insurance segment benefit ratio of 87.4% aligns with the previously disclosed expectation of approximately 87.5%.
In its prepared remarks, the company <a target="_blank" href="https://humana.gcs-web.com/static-files/04e1ec5b-ef37-44fc-bf21-0b5d2d6ac304" rel="noreferrer noopener">said</a>, &#8220;We are pleased with a solid start to 2025. Our first quarter Insurance segment benefit ratio of 87.4% reflects medical cost trends that developed in line with our expectations.&#8221;
The company states, &#8220;We remain committed to achieving an individual Medicare Advantage (MA) pretax margin of &#8216;at least 3%&#8217; over time and remain confident in our expectation that our 2025 MA pricing will drive the intended underlying margin improvement.&#8221;
Guidance: Humana expects 2025 GAAP sales of $126 billion-$128 billion versus the <a target="_blank" href="https://www.benzinga.com/25/02/43621782/insurance-giant-humanas-q4-earnings-at-par-with-estimates-2025-profit-outlook-falls-below-street-view" rel="noreferrer noopener">consensus of $126.21 billion</a>.
Sales guidance includes insurance segment sales of $121 billion—$123 billion and center-well segment sales of $20.5 billion—$21.5 billion.
The company said CenterWell Pharmacy was selected as the fulfillment pharmacy for NovoCare Pharmacy, operated by Novo Nordisk A/S&#8217; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) weight loss medication for cash-pay customers.
The insurer expects an annual membership decline of approximately 550,000 for individual Medicare Advantage, including the company&#8217;s decision to exit certain unprofitable plans and counties. Group Medicare Advantage will remain relatively flat, and Medicare stand-alone PDP growth will be approximately 200,000.
Humana reaffirms the 2025 adjusted EPS outlook of $16.25 versus the consensus of $16.35.
For 2025, Humana expects its insurance segment&#8217;s benefit ratio guidance of approximately 90.1-90.5%.
The company added, &#8220;Looking ahead, the 2026 final MA rate notice better reflects the medical cost trend environment and should enable greater stability within the industry as it serves the 34 million seniors who rely on the MA program.&#8221;
Price Action: HUM stock is down 0.80% at $257.28 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45105997/ge-healthcare-q1-earnings-beat-expectations-tariffs-to-impact-2025-profit-outlook" target="_blank" rel="noreferrer noopener">GE HealthCare Blames Tariffs For Lowering 2025 Profit Outlook, Initiates Stock Buyback</a></li>
</ul>
Photo by T. Schneider via Shutterstock

Large Cap

Guidance

Health Care

Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline

Wells Fargo analyst Eric Luebchow maintains American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) with a Overweight and raises the price target from $230 to $240.

Wells Fargo Maintains Overweight on American Tower, Raises Price Target to $240

Piper Sandler analyst Jason Bednar maintains Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) with a Neutral and lowers the price target from $18 to $17.

NVST

Piper Sandler Maintains Neutral on Envista Holdings, Lowers Price Target to $17

Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOLV#NYSE">SOLV</a>) with a Neutral and lowers the price target from $84 to $80.

SOLV

Piper Sandler Maintains Neutral on Solventum, Lowers Price Target to $80

The U.S. economy contracted for the first time in three years at the beginning of 2025 as a surge of imports ahead of Trump's tariffs pulled GDP negative<a href="https://www.benzinga.com/economics/macro-economic-events/25/04/45100047/recession-odds-spike-wall-street-tumbles-as-q1-gdp-surprisingly-contracts-be-patient-trump-responds"> in the first quarter.&nbsp;</a>
The Details: Gross domestic product declined by 0.3% on an annualized basis during the January–March period. The reading fell short of analyst expectations, which had forecast a modest slowdown to 0.4% growth.
On the jobs front, Automatic Data Processing Inc. reported that private employers added only 62,000 jobs in April, well below economists&#8217; expectations of 108,000.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/legal/25/04/45056354/alexandria-ocasio-cortez-askshow-much-did-majorie-taylor-greene-make-when-she-bought-the-dip?utm_source=articleShare">Alexandria Ocasio-Cortez Asks,&#8217;How Much Did Majorie Taylor Greene Make When She Bought The Dip?&#8217;</a>
Expert Ideas: Most economists agree that first-quarter GDP was "clouded" by a rush of imports as businesses increased inventories ahead of the implementation of Trump's tariff policies.&nbsp;
Jason Furman, professor of economics at Harvard University, highlighted that while GDP contracted, core GDP was up 3% at an annualized rate.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Real GDP fell at a 0.3% annual rate in Q1. The underlying numbers are very extreme&#8211;with an enormous increase in imports and inventories. My preferred measure of &quot;core GDP&quot; a better signal, up at a 3.0% annual rate (see next) <a href="https://t.co/oSJ7KBNqsa">pic.twitter.com/oSJ7KBNqsa</a>
&mdash; Jason Furman (@jasonfurman) <a href="https://twitter.com/jasonfurman/status/1917564370839650531?ref_src=twsrc%5Etfw">April 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Bill Adams, chief economist for Comerica Bank, cautioned that the first quarter GDP "says less than usual about the economy's trajectory" and pointed instead to April's ADP employment report as a more accurate barometer of economic conditions.&nbsp;
April's ADP private payrolls data came in well-below expectations and was the weakest monthly increase since July 2024.
"Between the GDP report, April's ADP report, and a pullback in business and consumer surveys last month, the economy is losing momentum and risks to the economic outlook are increasing," Adams said.&nbsp;
Jeffrey Roach, chief economist for LPL Financial, said the GDP report builds anticipation ahead of Friday's payroll numbers as the "trajectory for growth hinges on the health of the labor market."
Roach expressed the belief that the economy and U.S. consumer remain strong and that most of the economic turbulence is related to Trump's tariff policies.&nbsp;
"A successful resolution to global trade policy would likely remove most of the volatility and uncertainty currently experienced by businesses and consumers," Roach said.&nbsp;&nbsp;
Markets React: All three major indexes are in the red in Wednesday&#8217;s midday trading as they attempt to recover from steep declines following the GDP and ADP employment reports. The S&amp;P 500, tracked by the SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), was down 0.55% and the Nasdaq 100, tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), was down 1.29%. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/04/45076599/sell-in-may-and-go-away-only-in-bear-markets-one-expert-says?utm_source=articleShare">&#8216;Sell In May And Go Away?&#8217; Only In Bear Markets, One Expert Says&nbsp;</a></li>
</ul>
Photo: Shutterstock

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

As Growth Falters, Sentiment Slips, Economist Says 'Risks To The Economic Outlook Are Increasing'

Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) reported better-than-expected first-quarter financial results and raised its FY25 adjusted EPS <a href="https://www.benzinga.com/quote/HON/earnings">guidance on Tuesday</a>.
Revenue grew 8% year-over-year (Y/Y, organic: +4% Y/Y) to $9.82 billion, beating the consensus of $9.59 billion. Adjusted EPS was $2.51 (+7% Y/Y), beating the consensus of $2.21.
Honeywell declared a quarterly dividend per share of $1.13, payable on June 6, 2025, out of surplus to holders of record as of business on May 16, 2025.
For FY25, Honeywell revised its adjusted EPS guidance to $10.20-$10.50, from $10.10-$10.50 earlier (vs. consensus of $10.29) and sales guidance to $39.60 billion-$40.50 billion (from the prior $39.60 billion-$40.60 billion) compared to street view of $40.27 billion.
Honeywell anticipates second-quarter adjusted EPS of $2.60-$2.70, (vs. consensus of $2.56) and sales of $9.80 billion-$10.10 billion, slightly below the street view of $10.17 billion.
"Despite the volatile macroeconomic backdrop, we maintained segment margin consistent with last year, which is a testament to the value delivered by our Accelerator operating system," said Honeywell chairman and CEO Vimal Kapur.
Honeywell shares fell 0.9% to trade at $209.65 on Wednesday.
These analysts made changes to their price targets on Honeywell following earnings announcement.
<ul>
<li>Barclays analyst Julian Mitchell maintained Honeywell Intl with an Overweight rating and lowered the price target from $247 to $243.</li>
<li>RBC Capital analyst Deane Dray maintained Honeywell with a Sector Perform rating and raised the price target from $211 to $226.</li>
<li>Wells Fargo analyst Joseph O&#8217;Dea maintained the stock with an Equal-Weight rating and raised the price target from $205 to $225.</li>
</ul>
Considering buying HON stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="583" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30121653/image-237-1024x583.png" alt="" class="wp-image-895365" style="width:657px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30121653/image-237-1024x583.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30121653/image-237-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30121653/image-237-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30121653/image-237.png 1101w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

Honeywell Analysts Increase Their Forecasts After Upbeat Earnings

Piper Sandler analyst Derek Podhaizer maintains Solaris Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEI#NYSE">SEI</a>) with a Overweight and raises the price target from $50 to $51.

Comments

Brenmiller Energy

Noticias

Últimas noticias sobre Brenmiller Energy (NASDAQ:BNRG) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL